Dornan David's Insider Trades & SAST Disclosures
Dornan David's most recent trade in Elevation Oncology Inc was a trade of 9,375 Common Stock done . Disclosure was reported to the exchange on Feb. 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Dornan David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevation Oncology Inc | David Dornan | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 9,375 | 9,375 | - | - | Common Stock | |
| Elevation Oncology Inc | David Dornan | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 9,375 | 28,125 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | David Dornan | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 15 Feb 2025 | 4,152 | 5,223 | - | 0.7 | 2,789 | Common Stock |
| Elevation Oncology Inc | David Dornan | CHIEF SCIENTIFIC OFFICER | 15 Feb 2024 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | ||
| Elevation Oncology Inc | Dornan David | CHIEF SCIENTIFIC OFFICER | 15 Feb 2024 | 37,500 | 37,500 | - | - | Restricted Stock Unit | ||
| Elevation Oncology Inc | David Dornan | CHIEF SCIENTIFIC OFFICER | 15 Feb 2023 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | ||
| Elevation Oncology Inc | David Dornan | CHIEF SCIENTIFIC OFFICER | 06 Jan 2023 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | ||
| Elevation Oncology Inc | David Dornan | Chief Scientific Officer | 14 Mar 2022 | 230,000 | 230,000 | - | - | Employee Stock Option (right to buy) | ||
| Bolt Biotherapeutics Inc | David Dornan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | David Dornan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges